Chicago, ILNCT04796012Now EnrollingIRB Ready

Pediatric Cancer Clinical Trial in Chicago, IL

Access cutting-edge pediatric cancer treatment through this clinical trial at a research site in Chicago. Study-provided care at no cost to qualified participants.

Sponsored by University of Texas Southwestern Medical Center

Quick Self-Assessment

See if you qualify for this Chicago location

Preparing your pre-screening questions...

Expert Care in Chicago

Access pediatric cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pediatric cancer treatment provided free

Apply for This Chicago Location

Check if you qualify for this pediatric cancer clinical trial in Chicago, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Chicago

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Chicago site if eligible
  4. 4Begin participation

About This Pediatric Cancer Study in Chicago

This trial is a multi-center, non-randomized, open-label Phase I/II study evaluating the feasibility and efficacy of vincristine, irinotecan, temozolomide, and atezolizumab in children with relapsed/refractory solid tumors.

Sponsor: University of Texas Southwestern Medical Center

Who Can Participate

Inclusion Criteria

Signed informed consent 2. Relapsed or refractory solid tumor after at least one prior course of therapy. 1. Hodgkin lymphoma or non-Hodgkin lymphoma are not permitted. 2. Patients with CNS malignancy or asymptomatic CNS metastases may be enrolled, provided all of the following criteria are met.
No metastatic or primary disease affecting the brainstem, midbrain, pons, or cerebellum, or within 10 mm of optic nerve
No history of leptomeningeal disease
No history of intracranial or spinal cord hemorrhage
No evidence of progression of neurologic deficit, in the investigator's judgment, within 7 days prior to initiation of study medications. 3. Must have histologically confirmed rhabdomyosarcoma (RMS) for RMS efficacy cohort. 3. Age ≥ 6 months and ≤ 30 years 4. Lansky Performance Status (patients \< 16 years old) or Karnofsky Performance Status (patients ≥ 16 years old) ≥ 50 5. Ability to comply with the study protocol, in t

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Chicago?

Yes, this clinical trial (NCT04796012) has an active research site in Chicago, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pediatric Cancer Treatment Options in Chicago, IL

If you're searching for pediatric cancer treatment options in Chicago, IL, this clinical trial (NCT04796012) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Chicago research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pediatric cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pediatric cancer clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Chicago, IL

See all pulmonary embolism clinical trials recruiting in Chicago — not just this study.

Browse Pulmonary Embolism Trials in Chicago →

Browse More Trials by Condition

Pulmonary Embolism TrialsErectile Dysfunction TrialsInterstitial Cystitis TrialsPediatric Cancer TrialsAll Conditions →

Ready to Join in Chicago?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Chicago, IL